Diflucan May Be Related To Increased Risk of Congenital Heart Defects in Children

This week, the New England Journal of Medicine published Danish Researchers’  findings on whether low doses of Diflucan (a Pfizer medication) carry the same risk of birth defects that long term, high doses of the medication have seen, as referenced here. In August of 2011, the FDA changed the designation of high doses Diflucan from a Category C to a Category D pregnancy drug, which means that there is positive human evidence of a risk of birth defects and issued a drug safety communication about…
Continue reading...